UA110853U - METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA - Google Patents

METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA

Info

Publication number
UA110853U
UA110853U UAU201603548U UAU201603548U UA110853U UA 110853 U UA110853 U UA 110853U UA U201603548 U UAU201603548 U UA U201603548U UA U201603548 U UAU201603548 U UA U201603548U UA 110853 U UA110853 U UA 110853U
Authority
UA
Ukraine
Prior art keywords
activity
sensibilized
fasciolosis
atypic
mycobacteria
Prior art date
Application number
UAU201603548U
Other languages
Ukrainian (uk)
Inventor
Орест Володимирович Куляба
Володимир Володимирович Стибель
Ігор Богданович Турко
Богдан Володимирович Гутий
Володимир Іванович Семанюк
Original Assignee
Львівський Національний Університет Ветеринарної Медицини Та Біотехнологій Імені С.З. Гжицького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Львівський Національний Університет Ветеринарної Медицини Та Біотехнологій Імені С.З. Гжицького filed Critical Львівський Національний Університет Ветеринарної Медицини Та Біотехнологій Імені С.З. Гжицького
Priority to UAU201603548U priority Critical patent/UA110853U/en
Publication of UA110853U publication Critical patent/UA110853U/en

Links

Abstract

Спосіб корекції активності ензимів крові за фасціольозу сенсибілізованих атиповими мікобактеріями корів включає внутрішньом'язове введення хворим коровам клозаверму А у дозі 0,5 мл препарату на 10 кг маси тіла тварини. Крім цього, одночасно із клозавермом А додатково застосовують катозал внутрішньом'язово у дозі 10 мл препарату на тварину.A method of correcting the activity of blood enzymes for fasciitis sensitized by atypical mycobacterial cows involves intramuscular administration to sick cows clozaver A at a dose of 0.5 ml of the drug per 10 kg of body weight of the animal. In addition, at the same time with clozaverm And additionally use cozazal intramuscularly at a dose of 10 ml of the drug per animal.

UAU201603548U 2016-04-04 2016-04-04 METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA UA110853U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201603548U UA110853U (en) 2016-04-04 2016-04-04 METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201603548U UA110853U (en) 2016-04-04 2016-04-04 METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA

Publications (1)

Publication Number Publication Date
UA110853U true UA110853U (en) 2016-10-25

Family

ID=57232154

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201603548U UA110853U (en) 2016-04-04 2016-04-04 METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA

Country Status (1)

Country Link
UA (1) UA110853U (en)

Similar Documents

Publication Publication Date Title
CY1124135T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ROMRE'S DISEASE
EP4324521A3 (en) Treatment of fabry disease in ert-naive and ert-experienced patients
MX2017000366A (en) Combination therapy for cancer.
EA202190167A1 (en) SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY
RU2018125622A (en) METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS
MX2022003270A (en) Heterocyclic amide compound, pharmaceutically acceptable salt thereof, and preparation method therefor and use thereof.
TN2017000040A1 (en) Medical treatments based on anamorelin
RU2012136775A (en) METHOD AND MEANS FOR INCREASING ADAPTIVE POSSIBILITIES OF AN ATHLETES ORGANISM DURING THE TRAINING PROCESS
UA110853U (en) METHOD OF CORRECTION OF THE ACTIVITY OF BLOOD ENZYMES FOR FASCIOLOSIS OF SENSIBILIZED ATYPIC MYCOBACTERIA
EA201790991A1 (en) METHOD OF TREATMENT USING A PEGILATED INTERFERON
TR201908936T4 (en) Use of palmitoylethanolamide in combination with opioids.
EA201590350A1 (en) PEPTIDE COMBINATIONS WITH A CYCLIZED MAIN CHAIN
RU2016102018A (en) Method for correcting reproductive function in cows
UA112832U (en) METHOD OF CORRECTION OF FUNCTIONAL CONDITION OF BREATH LIVER IN FASCIOUS INVASION
RU2016112560A (en) METHOD FOR IMPROVING AN ANTIOXIDANT PROTECTION SYSTEM OF ANIMAL ORGANISM
UA115063U (en) METHOD OF TREATMENT OF DOGS WITH PAIN SYNDROME IN PANCREATITIS
RU2014104644A (en) METHOD FOR INCREASING THE EFFECTIVENESS OF TREATMENT OF COWS PATIENT WITH ACUTE PURULAR-CATARAL ENDOMETRITIS
UA95686U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
UA102567U (en) METHOD OF CORRECTION OF THE BODY IMMUNE SYSTEM IN ANTIBIOTICOTHERAPY IN THE TREATMENT OF RESPIRATORY DISEASES OF THE INFLAMMATORY CHARACTER
EA202090452A1 (en) COMPOUNDS FOR TREATMENT OF DISEASE VON HIPPEL-LINDAU
RU2013153993A (en) METHOD FOR CORRECTION OF THE THYROID STATUS OF BREEDING RABBIT RABBITS IN THE ENDEMIC ZONES BY THE COMBINED USE OF IODINE AND SELENIUM
EA202191570A1 (en) COMPOSITIONS FOR DELIVERY OF THERAPEUTIC DRUGS, METHODS OF THEIR APPLICATION AND OBTAINING
EA201990386A1 (en) COMPOUND AS A JAK SELECTIVE INHIBITOR AND ITS SALTS AND THERAPEUTIC USE
UA91458U (en) Method for correcting activity of enzymes in blood of fowl in treatment of eimeriosis
EA201991811A1 (en) PHARMACEUTICAL COMPOSITION, DOSAGE AND METHOD OF TREATMENT Ph + LEUKEMIA